(Q48412261)
Statements
Intranasal administration of TAT-haFGF(₁₄₋₁₅₄) attenuates disease progression in a mouse model of Alzheimer's disease (English)
Q Zhang
F Xiao
Q Xiang
Z Su
L Zhang
P Yang
Y Yang
Q Zheng
9 August 2012